Journal of Nanoparticle Research

, Volume 9, Issue 6, pp 1217–1220

A response to ‘Nanotechnology and the need for risk governance’, O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153–191

  • W. E. Bijker
  • I. D. de Beaufort
  • A. van den Berg
  • P. J. A. Borm
  • W. J. G. Oyen
  • G. T. Robillard
  • H. F. G. van Dijk
Brief Communication

DOI: 10.1007/s11051-007-9261-3

Cite this article as:
Bijker, W.E., de Beaufort, I.D., van den Berg, A. et al. J Nanopart Res (2007) 9: 1217. doi:10.1007/s11051-007-9261-3

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • W. E. Bijker
    • 1
  • I. D. de Beaufort
    • 2
  • A. van den Berg
    • 3
  • P. J. A. Borm
    • 4
    • 5
  • W. J. G. Oyen
    • 6
  • G. T. Robillard
    • 7
  • H. F. G. van Dijk
    • 8
  1. 1.Faculty of Arts and CultureUniversity MaastrichtMaastrichtThe Netherlands
  2. 2.Department of Medical EthicsErasmus Medical Center RotterdamRotterdamThe Netherlands
  3. 3.MESA+Institute, BIOS the Lab-on-a-chip GroupUniversity of TwenteEnschedeThe Netherlands
  4. 4.Center of Expertise in Life SciencesHogeschool ZuydHeerlenThe Netherlands
  5. 5.Institut für Umweltmedizinische ForschungHeinrich-Heine UniversityDusseldorfGermany
  6. 6.Department of Nuclear MedicineRadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  7. 7.BioMaDe TechnologyGroningenThe Netherlands
  8. 8.Health Council of the NetherlandsThe HagueThe Netherlands